bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine]
- RxCUI
- 1012406
- RxNorm name
- bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine]
- Display name
- MARCAINE (Injectable)
- Full name
- bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine]
- Term type
- SBD
- Status
- Active
- Strength
- 5 mg/ml
- Dose form
- Sol
- Route
- Injectable
- Updated
- 2026-10-27 17:46:41
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Solution | 316949 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Marcaine 0.5 % Injectable Solution | 1 | NAMES |
| RxNorm Name | bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1012406 | 1 | CODES |
| MMSL_CODE | BD1050 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-0525-25 | 0409-0525 | Marcaine BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | NDA016964 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 0409-0525-25 0409-0525 00409052525 00409052501 1012406 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 38 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20260529 |
| 56b90729-de15-4df9-9590-4da216fa9cd9 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 4 | P-Care K80MX | 20200203 |
| a7bceca8-7dda-4fff-80de-01858b90c928 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 4 | P-Care K40MX | 20200203 |
| 6a60cb55-530a-41ee-bc78-971eaf9f0850 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 4 | 20120307 | |
| 0029ecd1-a700-46a5-a5f9-c416fb2bb4f0 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 3 | Fossaoprin SPG4 Injection System | 20220222 |
| 5c32df04-cf50-45d5-9260-308ba585c407 | Marcaine 0.5 % Injectable Solution [PSN] · bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] [SBD] · Marcaine 0.5 % Injectable Solution [SY] · Marcaine 5 MG/ML Injectable Solution [SY] | 4 | 3 | Fossaoprin SPG2 Injection System | 20220222 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261023 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261014 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260529 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260423 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20251106 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250828 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250825 |
| e244561f-357d-4a9f-a26d-716dbf37814b | HiGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. | General Injectables & Vaccines, Inc | 20230413 |
| 28115cb6-118b-612a-e054-00144ff88e88 | ReadySharp-A | Terrain Pharmaceuticals | 20171219 |
| 433c1e4f-b7b7-4eda-e054-00144ff88e88 | ReadySharp Anesthetics + Dexamethasone | Terrain Pharmaceuticals | 20171219 |
| 43402281-92b1-61aa-e054-00144ff88e88 | ReadySharp Anesthetics + Ketorolac | Terrain Pharmaceuticals | 20171219 |
| 736cc923-1dc2-43e2-b0b9-178d9b0ba6dd | A-S Medication Solutions | 20171211 | |
| 2823a219-0466-5dda-e054-00144ff88e88 | ReadySharp-P80 | Terrain Pharmaceuticals | 20161213 |
| 28247e4a-0a18-0365-e054-00144ff88e88 | ReadySharp-P40 | Terrain Pharmaceuticals | 20161213 |
| 43775cf1-4477-449a-e054-00144ff88e88 | ReadySharp Anesthetics + Methylprednisolone 80 | Terrain Pharmaceuticals | 20161209 |
| 432c2026-99ec-49e0-e054-00144ff8d46c | ReadySharp Anesthetics + Betamethasone | Terrain Pharmaceuticals | 20161208 |
| f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | Proficient Rx LP | 20130530 | |
| 50473199-dfdf-43cc-a172-0796d1af30fc | National Council for Prescription Drug Programs | 20120724 | |
| 2d596c5c-df94-459f-ab85-48633ec02643 | National Council for Prescription Drug Programs | 20120724 | |
| 7976a937-5080-42c8-a0ba-a5fd0ed552ed | National Council for Prescription Drug Programs | 20120724 | |
| 9e377377-5a6a-40d4-99d0-12eb4969d433 | National Council for Prescription Drug Programs | 20120724 | |
| f93fc79b-36ff-402d-84b1-da9c820e076b | National Council for Prescription Drug Programs | 20120724 | |
| 6a60cb55-530a-41ee-bc78-971eaf9f0850 | Physicians Total Care, Inc. | 20120307 | |
| 8db7c501-993a-444d-a819-d1f9df1d7b62 | Marcaine (bupivacaine HCL) 0.5% Injection, USP 30 mL Single Dose Vial | General Injectables & Vaccines, Inc | 20110425 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA014901 |
| CODES | NDA | NDA016964 |
| NAMES | Prescribable Synonym | Marcaine 0.5 % Injectable Solution |
| NAMES | Tallman Synonym | BUPivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |